Biosimilars Market: Affordable Biologic Therapies Accelerate Growth Through 2035
The global biosimilars market is transforming the biopharmaceutical landscape by expanding access to high-quality biologic therapies at more affordable prices. The biosimilars market size is projected to grow from USD 35.04 billion in 2025 to USD 72.29 billion by 2035, registering a CAGR of 7.5% during the forecast period. The market was valued at USD 32.75 billion in 2024.
The increasing prevalence...
Biosimilars Market by Product & Manufacturing Type
Increasing demand for biosimilar drugs due to their cost-effectiveness, increasing incidences of chronic diseases, and strategic collaborations resulting in enhanced productivity and clinical trial activities are the key drivers for Biosimilars Market.
Breakdown of Primary Interviews
The products in biosimilars market include non-glycosylated proteins, recombinant glycosylated proteins, and recombinant...
Biosimilars Market by Product, manufacturing Type & Disease – 2023
The biosimilars market is expected to reach USD 23.63 billion by 2023 from USD 5.95 billion in 2018, at a CAGR of 31.7% during the forecast period. Growth in this market is mainly driven by factors such as rising incidence of chronic diseases and increasing demand for biosimilar drugs due to their cost-effectiveness.
Download PDF Brochure @ https://www.marketsandmarkets.com/pdfdownload.asp?id=40
On...